Reedy et al. v. Everlywell, Inc.
At-home lab tests; $5M in two subclass funds; approved May 2025.
Class action
Settled — final approval granted
Secondary source
Last verified Sep 8, 2026
Settled — final approval granted
Secondary source
Last verified Sep 8, 2026
The matter
- Matter ID
- SND-0134
- Organization
- Everlywell / Natalist
- Location
- National
- Provider type
- Clinical laboratory
- Court
- N.D. Ill.
- Docket
- 1:24-cv-02713
Timeline
- Filed
- 2024
- Final approval hearing
- Apr 29, 2025 (scheduled; outcome not yet recorded)
- Final approval order
- May 1, 2025
Outcome
- Structure
- Common fund
- Settlement fund
- $5,000,000
- Non-cash benefit
- pro rata by subclass
Status note
Settled $5,000,000 (Non-Sensitive Test Fund $2.36M; Sensitive Test Fund $2.64M). Final approval hearing Apr. 29, 2025; approved ~May 1, 2025.
Exposure
Pages covered Public website (unauthenticated)
Tracking technologies named
Plaintiff firms
Source
Data licensed under CC BY 4.0. Cite as SounderData.com Tracker Litigation Database, September 11, 2026.